{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:05:24Z","timestamp":1778335524093,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY1205"],"award-info":[{"award-number":["2024KY1205"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017599","name":"Science and Technology Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2024ZL219"],"award-info":[{"award-number":["2024ZL219"]}],"id":[{"id":"10.13039\/501100017599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.116011","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:30:13Z","timestamp":1765355413000},"page":"116011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Baicalin inhibits A549 cells proliferation and EMT through targeting the EGFR pathway"],"prefix":"10.1016","volume":"169","author":[{"given":"Zhisen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilin","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wencheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10299","key":"10.1016\/j.intimp.2025.116011_bb0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.intimp.2025.116011_bb0010","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1200\/JCO.23.01060","article-title":"Optimizing lung Cancer screening with risk prediction: current challenges and the emerging role of biomarkers","volume":"41","author":"Wu","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.116011_bb0015","article-title":"Screening high risk populations for lung cancer","volume":"376","author":"Melzer","year":"2022","journal-title":"BMJ"},{"issue":"18","key":"10.1016\/j.intimp.2025.116011_bb0020","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non-small-cell lung Cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.116011_bb0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-018-0777-1","article-title":"Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2025.116011_bb0030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2025.116011_bb0035","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12964-024-01775-8","article-title":"IL-1beta-activated PI3K\/AKT and MEK\/ERK pathways coordinately promote induction of partial epithelial-mesenchymal transition","volume":"22","author":"Tabei","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.intimp.2025.116011_bb0040","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-022-01646-1","article-title":"A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer","volume":"21","author":"Schinke","year":"2022","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2025.116011_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006624","article-title":"EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1\/2 in head and neck cancers","volume":"16","author":"Pan","year":"2018","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.116011_bb0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/path.6240","article-title":"A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction","volume":"262","author":"Pastorino","year":"2024","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116011_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbcan.2018.10.003","article-title":"EMT: a mechanism for escape from EGFR-targeted therapy in lung cancer","volume":"1871","author":"Tulchinsky","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"559","key":"10.1016\/j.intimp.2025.116011_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4589","article-title":"A YAP\/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components","volume":"12","author":"Nilsson","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.116011_bb0065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ccell.2023.01.007","article-title":"CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance","volume":"41","author":"Nilsson","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2025.116011_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155872","article-title":"Baicalin induces cell death of non-small cell lung cancer cells via MCOLN3-mediated lysosomal dysfunction and autophagy blockage","volume":"133","author":"Dong","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.116011_bb0075","article-title":"Baicalin induces apoptosis and suppresses the cell cycle progression of lung Cancer cells through downregulating Akt\/mTOR signaling pathway","volume":"7","author":"Sui","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.intimp.2025.116011_bb0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s40001-024-01930-4","article-title":"Baicalin promotes the sensitivity of NSCLC to cisplatin by regulating ferritinophagy and macrophage immunity through the KEAP1-NRF2\/HO-1 pathway","volume":"29","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.116011_bb0085","first-page":"3599","article-title":"Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting beta-catenin signaling","volume":"38","author":"Zhou","year":"2017","journal-title":"Oncol. Rep."},{"issue":"Pt A","key":"10.1016\/j.intimp.2025.116011_bb0090","article-title":"Schisandrin C inhibits AKT1-regulated cell proliferation in A549 cells","volume":"142","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.116011_bb0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41591-019-0750-6","article-title":"Regenerative lineages and immune-mediated pruning in lung cancer metastasis","volume":"26","author":"Laughney","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2025.116011_bb0100","doi-asserted-by":"crossref","first-page":"38646","DOI":"10.1038\/srep38646","article-title":"Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.116011_bb0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13020-022-00581-z","article-title":"Cucurbitacin B inhibits TGF-beta1-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K\/Akt\/mTOR pathways","volume":"17","author":"Yuan","year":"2022","journal-title":"Chin. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.116011_bb0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.14740\/wjon1518","article-title":"A ROS\/Akt\/NF-kappaB signaling Cascade mediates epidermal growth factor-induced epithelial-mesenchymal transition and invasion in human breast Cancer cells","volume":"13","author":"Min","year":"2022","journal-title":"World. J. Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2025.116011_bb0115","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s11427-023-2499-2","article-title":"Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K\/Akt\/mTOR pathway","volume":"67","author":"Ganesan","year":"2024","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.116011_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12974-019-1474-8","article-title":"Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K\/AKT\/FoxO1 pathway","volume":"16","author":"Guo","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2025.116011_bb0125","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.2147\/DDDT.S319260","article-title":"Baicalin alleviates oxidative stress and inflammation in diabetic nephropathy via Nrf2 and MAPK signaling pathway","volume":"15","author":"Ma","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2025.116011_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155296","article-title":"Baicalin ameliorates insulin resistance and regulates hepatic glucose metabolism via activating insulin signaling pathway in obese pre-diabetic mice","volume":"124","author":"Miao","year":"2024","journal-title":"Phytomedicine"},{"issue":"21","key":"10.1016\/j.intimp.2025.116011_bb0135","article-title":"Mechanisms of Baicalin alleviates intestinal inflammation: role of M1 macrophage polarization and lactobacillus amylovorus","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.intimp.2025.116011_bb0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1142\/S0192415X23500118","article-title":"Baicalin blocks Colon Cancer cell cycle and inhibits cell proliferation through miR-139-3p upregulation by targeting CDK16","volume":"51","author":"Cai","year":"2023","journal-title":"Am. J. Chin. Med."},{"issue":"7","key":"10.1016\/j.intimp.2025.116011_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.01.002","article-title":"Baicalin reduces chronic stress-induced breast cancer metastasis via directly targeting beta2-adrenergic receptor","volume":"14","author":"Jia","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.intimp.2025.116011_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154881","article-title":"Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2\/xCT\/GPX4 regulatory axis","volume":"116","author":"Wen","year":"2023","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.intimp.2025.116011_bb0155","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.apsb.2021.03.036","article-title":"Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1","volume":"11","author":"Kong","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.116011_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114986","article-title":"Baicalin enhances the efficacy of 5-fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis","volume":"164","author":"Yuan","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.intimp.2025.116011_bb0165","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa0904554","article-title":"G. Spanish Lung Cancer, Screening for epidermal growth factor receptor mutations in lung cancer","volume":"361","author":"Rosell","year":"2009","journal-title":"N Engl. J. Med."},{"issue":"15","key":"10.1016\/j.intimp.2025.116011_bb0170","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1200\/JCO.2010.32.6181","article-title":"Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas","volume":"29","author":"D\u2019Angelo","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"7511","key":"10.1016\/j.intimp.2025.116011_bb0175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Cancer genome atlas research, comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"N.","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2025.116011_bb0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/JTO.0000000000000033","article-title":"A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)","volume":"9","author":"Shi","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116011_bb0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13046-025-03531-3","article-title":"Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation","volume":"44","author":"Liu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.intimp.2025.116011_bb0190","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.2010.33.4235","article-title":"Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin\/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS)","volume":"29","author":"Fukuoka","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2025.116011_bb0195","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1158\/1078-0432.CCR-10-2692","article-title":"Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation","volume":"17","author":"Oxnard","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.intimp.2025.116011_bb0200","article-title":"Honokiol-Magnolol-Baicalin possesses synergistic anticancer potential and enhances the efficacy of anti-PD-1 immunotherapy in colorectal Cancer by triggering GSDME-dependent Pyroptosis","volume":"12","author":"Gao","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.intimp.2025.116011_bb0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13045-014-0087-z","article-title":"Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application","volume":"7","author":"Yuan","year":"2014","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"10.1016\/j.intimp.2025.116011_bb0210","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.7150\/jca.30463","article-title":"Prognostic value of site-specific metastases in lung cancer: a population based study","volume":"10","author":"Li","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2025.116011_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117714","article-title":"Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers","volume":"181","author":"Yuan","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"17","key":"10.1016\/j.intimp.2025.116011_bb0220","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","article-title":"Tumor immune microenvironment during epithelial-mesenchymal transition","volume":"27","author":"Taki","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.116011_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","article-title":"TGF-beta, EMT, and resistance to anti-cancer treatment","volume":"97","author":"Wang","year":"2023","journal-title":"Semin. Cancer Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:31:27Z","timestamp":1771511487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925020004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"alternative-id":["S1567576925020004"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116011","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baicalin inhibits A549 cells proliferation and EMT through targeting the EGFR pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116011"}}